Monday, December 23, 2024
HomeTagsBasilea Pharmaceutica

Basilea Pharmaceutica

Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891

Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with cancer and infectious diseases, announced today that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics